| Net income (loss) | 350.1M |
| Asset impairments | |
| Charged to depreciation and amortization | |
| Charged to other accounts | |
| Other | |
| Deferred income taxes | 193.56M |
| Other | |
| Net assets / liabilities from risk management activities | |
| Net change in operating assets and liabilities | |
| Net cash provided by operating activities | 794.99M |
| Capital expenditures | -1.09B |
| Other, net | 6.46M |
| Net cash used in investing activities | -1.08B |
| Net increase in short-term debt | 371.88M |
| Net proceeds from issuance of long-term debt | 0 |
| Settlement of Treasury lock agreement | |
| Unwinding of Treasury lock agreements | -317K |
| Repayment of long-term debt | 0 |
| Cash dividends paid | -175.13M |
| Repurchase of equity awards | |
| Issuance of common stock | 98.57M |
| Net cash provided by (used in) financing activities | 303.62M |
| Net increase (decrease) in cash and cash equivalents | 18.88M |
| Cash and cash equivalents at beginning of period | 28.65M |
| Cash and cash equivalents at end of period | 47.53M |